Novogen Fpo (delisted) News - NRT

MARKET SNAPSHOT: U.S. Stocks: Futures Lower As Investors Bide Their Time For Jobs Data

By Sara Sjolin, MarketWatch LONDON (MarketWatch) -- U.S. stock futures pointed to another day in the red on Wednesday, with investors cautious...

ABC TV Interview Discusses the Potential of Trilexium(TM) to Treat Brain Cancer

ABC TV Interview Discusses the Potential of Trilexium(TM) to Treat Brain Cancer PR Newswire SYDNEY, Sept. 29, 2014 SYDNEY, Sept. 29, 2014...

ABC TV Interview Discusses the Potential of Trilexium(TM) to Treat Brain Cancer

ABC TV Interview Discusses the Potential of Trilexium(TM) to Treat Brain Cancer PR Newswire SYDNEY, Sept. 29, 2014 SYDNEY, Sept. 29, 2014...

Novogen Announces Presentation at Rodman & Renshaw 16th Annual Healthcare Conference

Novogen Announces Presentation at Rodman & Renshaw 16th Annual Healthcare Conference PR Newswire SYDNEY, Sept. 3, 2014 SYDNEY, Sept. 3, 2014...

Novogen Receives Funding Support To Commence Studies In Muscular Dystrophy

Novogen Receives Funding Support To Commence Studies In Muscular Dystrophy PR Newswire SYDNEY, Aug. 12, 2014 SYDNEY, Aug. 12, 2014 /PRNewswire/...

Novogen And CanTx Appoint Contract Manufacturers To Produce Clinical Batches Of Cantrixil™

Novogen And CanTx Appoint Contract Manufacturers To Produce Clinical Batches Of Cantrixil™ Phase I studies start in 2015 PR Newswire NEW HAVEN...

Novogen and CanTx Announce Potency of Intra-Peritoneal Trx-1 Confirmed Against Chemo-Resistant Ovarian Cancer Stem Cells

Novogen and CanTx Announce Potency of Intra-Peritoneal Trx-1 Confirmed Against Chemo-Resistant Ovarian Cancer Stem Cells Companies expect to...

Novogen Identifies Highly Active Drug Candidates Against Prostate Cancer

Novogen Identifies Highly Active Drug Candidates Against Prostate Cancer PR Newswire SYDNEY, May 27, 2014 SYDNEY, May 27, 2014 /PRNewswire/...

Children's Oncology Drug Alliance (CODA) Formed to Facilitate Development of Treatments for Childhood Cancers

Children's Oncology Drug Alliance (CODA) Formed to Facilitate Development of Treatments for Childhood Cancers Alliance of Australian and U.S...

Novogen and Genea Announce Partnership to Investigate Promising New Approach to Neurodegenerative Diseases

Novogen and Genea Announce Partnership to Investigate Promising New Approach to Neurodegenerative Diseases PR Newswire SYDNEY, May 2, 2014...

Novogen and CanTx Experimental Drug, Trx-1, Proves Effective in Vivo

Novogen and CanTx Experimental Drug, Trx-1, Proves Effective in Vivo Experimental drug designed to fight abdominal cancers passes important...

Novogen to Present at 2nd Annual Sachs Cancer Bio Partnering & Investment Forum in New York

Novogen to Present at 2nd Annual Sachs Cancer Bio Partnering & Investment Forum in New York PR Newswire SYDNEY, March 12, 2014 SYDNEY, March...

Novogen Selected to Present at Cavendish Global Health Impact Forum

Novogen Selected to Present at Cavendish Global Health Impact Forum Forum uniquely brings together leading family offices and their foundations...

Novogen Appoints New Board Members and Strategic Advisor to Support Transition to Clinical Development and Growing Internatio...

Novogen Appoints New Board Members and Strategic Advisor to Support Transition to Clinical Development and Growing International Presence PR...

Novogen Announces Key Appointments to Drive Development of Anti-Tropomyosin Drug Platform

Novogen Announces Key Appointments to Drive Development of Anti-Tropomyosin Drug Platform Co-inventors of ATM technology joining company as...

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Novogen Fpo (delisted) (NRT)

Professional-Grade Tools, for Individual Investors.

NRT News

MARKET SNAPSHOT: U.S. Stocks: Futures Lower As Investors Bide Their Time For Jobs Data

ABC TV Interview Discusses the Potential of Trilexium(TM) to Treat Brain Cancer

ABC TV Interview Discusses the Potential of Trilexium(TM) to Treat Brain Cancer

Novogen Announces Presentation at Rodman & Renshaw 16th Annual Healthcare Conference

Novogen Receives Funding Support To Commence Studies In Muscular Dystrophy

Novogen And CanTx Appoint Contract Manufacturers To Produce Clinical Batches Of Cantrixil™

Novogen and CanTx Announce Potency of Intra-Peritoneal Trx-1 Confirmed Against Chemo-Resistant Ovarian Cancer Stem Cells

Novogen Identifies Highly Active Drug Candidates Against Prostate Cancer

Children's Oncology Drug Alliance (CODA) Formed to Facilitate Development of Treatments for Childhood Cancers

Novogen and Genea Announce Partnership to Investigate Promising New Approach to Neurodegenerative Diseases

Novogen and CanTx Experimental Drug, Trx-1, Proves Effective in Vivo

Novogen to Present at 2nd Annual Sachs Cancer Bio Partnering & Investment Forum in New York

Novogen Selected to Present at Cavendish Global Health Impact Forum

Novogen Appoints New Board Members and Strategic Advisor to Support Transition to Clinical Development and Growing Internatio...

Novogen Announces Key Appointments to Drive Development of Anti-Tropomyosin Drug Platform

NRT Discussion

Your Recent History

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Novogen Fpo (delisted) (NRT) News

Novogen Fpo (delisted) (NRT)

Professional-Grade Tools, for Individual Investors.

NRT News

MARKET SNAPSHOT: U.S. Stocks: Futures Lower As Investors Bide Their Time For Jobs Data

ABC TV Interview Discusses the Potential of Trilexium(TM) to Treat Brain Cancer

ABC TV Interview Discusses the Potential of Trilexium(TM) to Treat Brain Cancer

Novogen Announces Presentation at Rodman & Renshaw 16th Annual Healthcare Conference

Novogen Receives Funding Support To Commence Studies In Muscular Dystrophy

Novogen And CanTx Appoint Contract Manufacturers To Produce Clinical Batches Of Cantrixil™

Novogen and CanTx Announce Potency of Intra-Peritoneal Trx-1 Confirmed Against Chemo-Resistant Ovarian Cancer Stem Cells

Novogen Identifies Highly Active Drug Candidates Against Prostate Cancer

Children's Oncology Drug Alliance (CODA) Formed to Facilitate Development of Treatments for Childhood Cancers

Novogen and Genea Announce Partnership to Investigate Promising New Approach to Neurodegenerative Diseases

Novogen and CanTx Experimental Drug, Trx-1, Proves Effective in Vivo

Novogen to Present at 2nd Annual Sachs Cancer Bio Partnering & Investment Forum in New York

Novogen Selected to Present at Cavendish Global Health Impact Forum

Novogen Appoints New Board Members and Strategic Advisor to Support Transition to Clinical Development and Growing Internatio...

Novogen Announces Key Appointments to Drive Development of Anti-Tropomyosin Drug Platform

NRT Discussion

Your Recent History